semaglutide vs. tirzepatide for Weight Loss: Results, Side Effects & How to Choose Semaglutide vs Tirzepatide: Which GLP-1

Medicare Part D excludes agents used for weight loss by statute, though CMS launched the Medicare GLP-1 Bridge demonstration running July 1, 2026 through December 31, 2027, offering eligible beneficiaries certain GLP-1 drugs at a $50 copay outside the standard benefit

Long-Term Support We dont just prescribe and disappear

Our clinic brings medical weight loss and hormone therapy together under one roof, giving residents across Indianapoliss northeast corridor a coordinated, clinically grounded approach to better health without the need to navigate multiple providers

It hasn't been approved anywhere yet

"That was the first time I was able to say as an obesity medicine specialist that if I give you this drug, I can likely improve your life and reduce your chance of dying from cardiovascular disease

When Is the Best Time to Weigh Yourself